Back
Marinus Pharmaceuticals Stock Price Chart
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Sell
50
MRNS
Marinus Pharmaceuticals
Last Price:
1.61
Seasonality Move:
6.86%
7 Day Trial
ALL ACCESS PASS
$
7
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MRNS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Marinus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.49 | Buy |
| 20-day SMA: | 1.44 | Buy |
| 50-day SMA: | 1.37 | Buy |
| 200-day SMA: | 5.01 | Sell |
| 8-day EMA: | 1.51 | Buy |
| 20-day EMA: | 1.45 | Buy |
| 50-day EMA: | 1.49 | Buy |
| 200-day EMA: | 3.77 | Sell |
Marinus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 67.45 | Buy |
| Chaikin Money Flow: | 293553 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.32 - 1.5) | Buy |
| Bollinger Bands (100): | (1.27 - 1.49) | Buy |
Marinus Pharmaceuticals Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Marinus Pharmaceuticals Stock
Is Marinus Pharmaceuticals Stock a Buy?
- Marinus Pharmaceuticals share price is 1.61 while MRNS 8-day simple moving average is 1.49, which is a Buy signal.
- The stock price of MRNS is 1.61 while Marinus Pharmaceuticals 20-day SMA is 1.44, which makes it a Buy.
- Marinus Pharmaceuticals 50-day simple moving average is 1.37 while MRNS share price is 1.61, making it a Buy technically.
- MRNS stock price is 1.61 and Marinus Pharmaceuticals 200-day simple moving average is 5.01, creating a Sell signal.
MRNS Technical Analysis vs Fundamental Analysis
Sell
50
Marinus Pharmaceuticals (MRNS)
is a Sell
Is Marinus Pharmaceuticals a Buy or a Sell?
-
Marinus Pharmaceuticals stock is rated a Sell
The current Marinus Pharmaceuticals [MRNS] share price is $1.61. The Score for MRNS is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Marinus Pharmaceuticals Stock Info
Market Cap:
88.41M
Price in USD:
1.61
Share Volume:
420.63K
Marinus Pharmaceuticals 52-Week Range
52-Week High:
11.26
52-Week Low:
1.05
Sell
50
Marinus Pharmaceuticals (MRNS)
is a Sell
Marinus Pharmaceuticals Share Price Forecast
-
What is the Marinus Pharmaceuticals stock price today?
The Marinus Pharmaceuticals stock price is 1.61 USD today. -
Will MRNS stock go up or go down?
Marinus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Marinus Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Marinus Pharmaceuticals is overvalued.
Is Marinus Pharmaceuticals Stock a Buy?
- Marinus Pharmaceuticals share price is 1.61 while MRNS 8-day exponential moving average is 1.51, which is a Buy signal.
- The stock price of MRNS is 1.61 while Marinus Pharmaceuticals 20-day EMA is 1.45, which makes it a Buy.
- Marinus Pharmaceuticals 50-day exponential moving average is 1.49 while MRNS share price is 1.61, making it a Buy technically.
- MRNS stock price is 1.61 and Marinus Pharmaceuticals 200-day simple moving average is 3.77, creating a Sell signal.
Fundamental Analysis of Marinus Pharmaceuticals
Is Marinus Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.21 per share, an increase this year of $0.63 per share, and an increase next year of $0.90 per share.
Technical Analysis of Marinus Pharmaceuticals
Should I short Marinus Pharmaceuticals stock?
- MRNS Moving Average Covergence Divergence (MACD) indicator is 0.06, suggesting Marinus Pharmaceuticals is a Buy
- Marinus Pharmaceuticals Relative Strength Index (RSI) is 67.45, which suggest Marinus Pharmaceuticals is overbought
- The Bollinger Bands (25) for Marinus Pharmaceuticals is (1.32 - 1.5), which suggest Marinus Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Marinus Pharmaceuticals is (1.27 - 1.49), which suggest Marinus Pharmaceuticals is a Buy
* Marinus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.